305 related articles for article (PubMed ID: 25573806)
21. Synthesis and spectral characterization of Schiff base complexes of Cu(II), Co(II), Zn(II) and VO(IV) containing 4-(4-aminophenyl)morpholine derivatives: antimicrobial evaluation and anticancer studies.
Dhahagani K; Mathan Kumar S; Chakkaravarthi G; Anitha K; Rajesh J; Ramu A; Rajagopal G
Spectrochim Acta A Mol Biomol Spectrosc; 2014 Jan; 117():87-94. PubMed ID: 23985482
[TBL] [Abstract][Full Text] [Related]
22. Copper(I) and nickel(II) complexes with 1:1 vs. 1:2 coordination of ferrocenyl hydrazone ligands: do the geometry and composition of complexes affect DNA binding/cleavage, protein binding, antioxidant and cytotoxic activities?
Krishnamoorthy P; Sathyadevi P; Butorac RR; Cowley AH; Bhuvanesh NS; Dharmaraj N
Dalton Trans; 2012 Apr; 41(15):4423-36. PubMed ID: 22344370
[TBL] [Abstract][Full Text] [Related]
23. Copper Ion Attenuated the Antiproliferative Activity of Di-2-pyridylhydrazone Dithiocarbamate Derivative; However, There Was a Lack of Correlation between ROS Generation and Antiproliferative Activity.
Wang T; Fu Y; Huang T; Liu Y; Wu M; Yuan Y; Li S; Li C
Molecules; 2016 Aug; 21(8):. PubMed ID: 27556432
[TBL] [Abstract][Full Text] [Related]
24. Mixed-ligand mononuclear copper(II) complex: crystal structure and anticancer activity.
Qin XY; Liu YN; Yu QQ; Yang LC; Liu Y; Zhou YH; Liu J
ChemMedChem; 2014 Aug; 9(8):1665-71. PubMed ID: 24839939
[TBL] [Abstract][Full Text] [Related]
25. Nitroimidazole and glucosamine conjugated heteroscorpionate ligands and related copper(II) complexes. Syntheses, biological activity and XAS studies.
Pellei M; Papini G; Trasatti A; Giorgetti M; Tonelli D; Minicucci M; Marzano C; Gandin V; Aquilanti G; Dolmella A; Santini C
Dalton Trans; 2011 Oct; 40(38):9877-88. PubMed ID: 21709917
[TBL] [Abstract][Full Text] [Related]
26. Influence of anchoring moieties on new benzimidazole-based Schiff base copper(II) complexes towards estrogen dependent breast cancer cells.
Paul A; Singh P; Kuznetsov ML; Karmakar A; Guedes da Silva MFC; Koch B; Pombeiro AJL
Dalton Trans; 2021 Mar; 50(10):3701-3716. PubMed ID: 33634805
[TBL] [Abstract][Full Text] [Related]
27. Design of an Anticancer Copper(II) Prodrug Based on the Lys199 Residue of the Active Targeting Human Serum Albumin Nanoparticle Carrier.
Gou Y; Zhang Y; Zhang Z; Wang J; Zhou Z; Liang H; Yang F
Mol Pharm; 2017 Jun; 14(6):1861-1873. PubMed ID: 28471669
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, DNA/HSA Interaction Spectroscopic Studies and In Vitro Cytotoxicity of a New Mixed Ligand Cu(II) Complex.
Gan Q; Fu X; Chen W; Xiong Y; Fu Y; Chen S; Le X
J Fluoresc; 2016 May; 26(3):905-18. PubMed ID: 26961845
[TBL] [Abstract][Full Text] [Related]
29. Syntheses, Crystal Structures, and Antitumor Activities of Copper(II) and Nickel(II) Complexes with 2-((2-(Pyridin-2-yl)hydrazono)methyl)quinolin-8-ol.
Yang QY; Cao QQ; Qin QP; Deng CX; Liang H; Chen ZF
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29949884
[TBL] [Abstract][Full Text] [Related]
30. Two water-soluble copper(II) complexes: synthesis, characterization, DNA cleavage, protein binding activities and in vitro anticancer activity studies.
Lu J; Sun Q; Li JL; Jiang L; Gu W; Liu X; Tian JL; Yan SP
J Inorg Biochem; 2014 Aug; 137():46-56. PubMed ID: 24803026
[TBL] [Abstract][Full Text] [Related]
31. Water-soluble DNA minor groove binders as potential chemotherapeutic agents: synthesis, characterization, DNA binding and cleavage, antioxidation, cytotoxicity and HSA interactions.
Fu XB; Liu DD; Lin Y; Hu W; Mao ZW; Le XY
Dalton Trans; 2014 Jun; 43(23):8721-37. PubMed ID: 24770345
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, crystal structure and biological activities of a novel amidrazone derivative and its copper(II) complex--a potential antitumor drug.
Mazur L; Modzelewska-Banachiewicz B; Paprocka R; Zimecki M; Wawrzyniak UE; Kutkowska J; Ziółkowska G
J Inorg Biochem; 2012 Sep; 114():55-64. PubMed ID: 22694858
[TBL] [Abstract][Full Text] [Related]
33. Ternary copper(II) complexes with amino acid chains and heterocyclic bases: DNA binding, cytotoxic and cell apoptosis induction properties.
Ma T; Xu J; Wang Y; Yu H; Yang Y; Liu Y; Ding W; Zhu W; Chen R; Ge Z; Tan Y; Jia L; Zhu T
J Inorg Biochem; 2015 Mar; 144():38-46. PubMed ID: 25555321
[TBL] [Abstract][Full Text] [Related]
34. Structure-activity relationship study of copper(II) complexes with 2-oxo-1,2-dihydroquinoline-3-carbaldehyde (4'-methylbenzoyl) hydrazone: synthesis, structures, DNA and protein interaction studies, antioxidative and cytotoxic activity.
Raja DS; Bhuvanesh NS; Natarajan K
J Biol Inorg Chem; 2012 Feb; 17(2):223-37. PubMed ID: 21932155
[TBL] [Abstract][Full Text] [Related]
35. Mechanistic insights into a novel chromone-appended Cu(II) anticancer drug entity: in vitro binding profile with DNA/RNA substrates and cytotoxic activity against MCF-7 and HepG2 cancer cells.
Yousuf I; Arjmand F; Tabassum S; Toupet L; Khan RA; Siddiqui MA
Dalton Trans; 2015 Jun; 44(22):10330-42. PubMed ID: 25970097
[TBL] [Abstract][Full Text] [Related]
36. Induction of Apoptosis by Nano-Synthesized Complexes of H2L and its Cu(II) Complex in Human Hepatocellular Carcinoma Cells.
Diab T; Mohamed TM; Hamed A; Gaber M
Anticancer Agents Med Chem; 2021; 21(9):1151-1159. PubMed ID: 32013853
[TBL] [Abstract][Full Text] [Related]
37. Concentration dependent tautomerism in green [Cu(HL¹)(L²)] and brown [Cu(L¹)(HL²)] with H₂L¹ = (E)-N'-(2-hydroxy-3-methoxybenzylidene)benzoylhydrazone and HL² = pyridine-4-carboxylic (isonicotinic) acid.
Monfared HH; Vahedpour M; Yeganeh MM; Ghorbanloo M; Mayer P; Janiak C
Dalton Trans; 2011 Feb; 40(6):1286-94. PubMed ID: 21203633
[TBL] [Abstract][Full Text] [Related]
38. Developing an Anticancer Copper(II) Pro-Drug Based on the His242 Residue of the Human Serum Albumin Carrier IIA Subdomain.
Qi J; Zhang Y; Gou Y; Zhang Z; Zhou Z; Wu X; Yang F; Liang H
Mol Pharm; 2016 May; 13(5):1501-7. PubMed ID: 27017838
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, characterization and the interaction of some new water-soluble metal Schiff base complexes with human serum albumin.
Asadi M; Asadi Z; Sadi SB; Zarei L; Baigi FM; Amirghofran Z
Spectrochim Acta A Mol Biomol Spectrosc; 2014 Mar; 122():118-29. PubMed ID: 24299984
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and crystal structure elucidation of new copper(II)-based chemotherapeutic agent coupled with 1,2-DACH and orthovanillin: Validated by in vitro DNA/HSA binding profile and pBR322 cleavage pathway.
Zaki M; Afzal M; Ahmad M; Tabassum S
J Photochem Photobiol B; 2016 Aug; 161():318-27. PubMed ID: 27289445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
